Regenmed Development Organization
Regenmed Development Organization consistently operates near break-even with no reported officer compensation.
EIN: 202710571 · Winstonsalem, NC · NTEE: H12 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $4.1M |
| Total Expenses | $1.2M |
| Program Spending | 85% |
| Net Assets | $-35,387 |
| Transparency Score | 85/100 |
Search Intent Cockpit
Regenmed Development Organization Form 990, Revenue, CEO Pay, and IRS Filing Signals
Regenmed Development Organization is surfaced here as a decision-ready nonprofit financial profile, not just a charity listing. The page consolidates IRS Form 990 revenue, expenses, assets, tax-exempt classification, executive compensation, mission score, red flags, and year-by-year filing history so donors, researchers, journalists, and grant teams can answer the common search questions around Regenmed Development Organization in one place.
Form 990 Filing Summary
14 filing years are available, with latest revenue of $1.2M and expenses of $1.2M.
Revenue and Expenses
Regenmed Development Organization reported $1.2M in revenue and $1.2M in expenses, a deficit of $15K.
Executive Compensation
Officer, director, trustee, and key employee pay is reviewed from IRS 990 compensation disclosures when present.
Charity Score and Red Flags
85/100 mission score, 3 red flags, and 3 strengths are shown from structured and AI review.
Is Regenmed Development Organization Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
IRS 990 Data Cockpit
Where the Money Comes From and Where It Goes
Revenue Source Mix
Revenue-source line items are not available on the stored filing yet. Future ingestion now preserves contribution, program-revenue, and investment-income fields when ProPublica provides them.
Expense Deployment
| Program services | $1.0M (85%) |
Across stored filings, Regenmed Development Organization shows contribution history pending. Next enrichment targets: revenue-source fields, IRS BMF classification.
Decision Cockpit
One-Stop Donor, Research, and Peer Context Hub
| Decision Lens | Signal | What to Inspect Next |
|---|---|---|
| Legitimacy | Some Concerns | Good filing record; 3 red flags identified |
| Mission spend | 85% to programs | Excellent |
| Financial durability | Grade C | 14 stored filing years |
| Peer context | Compare with Cccp Community Trust | North Carolina and Category H context |
Trust Check
Review legitimacy, deductibility, red flags, and filing consistency.
Open charity check →Peer Benchmark
Compare against real state and category peers.
Compare with Cccp Community Trust →All North Carolina nonprofits
All Category H
Local and Sector Spokes
Move into this nonprofit's local market, category, and sector maps.
Winstonsalem, NC nonprofitsCategory H in North Carolina
Health in North Carolina
Follow the Money
Jump into spending, compensation, rankings, and filing-year evidence.
State spending analysisState compensation analysis
Category H spending
Best Category H charities in North Carolina
Relevant rankings
Donation Decision Flow
From Trust Check to Better Alternatives
Alternative Shopping
Similar Nonprofits Donors Should Compare
Childrens Hope Alliance
Statesville, NC · $23.5M revenue · Score 95/100
Compare side-by-sideOrthocarolina Research Institute Inc
Charlotte, NC · $2.6M revenue · Score 85/100
Compare side-by-sideDare County Education Foundation Inc
Kitty Hawk, NC · $601K revenue · Score 92/100
Compare side-by-sidePaws For Life Nc
Youngsville, NC · $424K revenue · Score 92/100
Compare side-by-sideNext Best Actions
Keep the Investigation Moving
Regenmed Development Organization directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Regenmed Development Organization
Regenmed Development Organization (EIN: 202710571) is a nonprofit organization based in Winstonsalem, NC, classified under NTEE code H12. The organization reported total revenue of $4.1M and total assets of $7.8M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Regenmed Development Organization's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Regenmed Development Organization is a mid-size nonprofit that has been operating for 21 years, with 14 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 17.9%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $1.2M |
| Total Expenses | $1.2M |
| Surplus / Deficit | $-15,219 |
| Total Assets | $565K |
| Total Liabilities | $601K |
| Net Assets | $-35,387 |
| Operating Margin | -1.3% |
| Debt-to-Asset Ratio | 106.3% |
| Months of Reserves | 5.7 months |
Financial Health Grade: C
In 2023, Regenmed Development Organization reported a deficit of $15K with expenses exceeding revenue, holds 5.7 months of operating reserves (adequate), has a debt-to-asset ratio of 106.3% (high leverage).
Financial Trends
Over 14 years of filings (2011–2023), Regenmed Development Organization's revenue has grown at a compound annual growth rate (CAGR) of 17.9%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +18.5% | +16.3% | -82.4% |
| 2022 | -8.9% | -7.1% | +67.1% |
| 2021 | -46.5% | -47.0% | +126.5% |
| 2021 | -5.1% | -4.7% | -42.9% |
| 2020 | +3.5% | +2.9% | -55.2% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2100 |
| IRS Ruling Date | 2005 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Regenmed Development Organization with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, Regenmed Development Organization allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $15K, with expenses exceeding revenue.
- Debt-to-asset ratio: 106.3%.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation across all 14 available filings, indicating that no funds are allocated to executive salaries, which is highly unusual for an organization of its size and revenue, and suggests a volunteer-led or externally funded leadership structure.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Regenmed Development Organization's IRS 990 filings:
- Significant fluctuation and decline in assets from $3.3M in 2019 to $0.56M in 2023 without clear explanation.
- Liabilities frequently exceed or closely match assets, indicating a potentially precarious financial position (e.g., 2023: $600,696 liabilities vs. $565,309 assets).
- Consistent near break-even operations with minimal surplus generation, limiting capacity for reserves or future investment.
Strengths
The following positive indicators were identified for Regenmed Development Organization:
- Consistent reporting of 0% officer compensation, indicating a strong commitment to directing funds to the mission.
- Stable revenue generation over several years, demonstrating consistent donor or grant support.
- Long filing history (14 filings) suggests established operations and compliance with IRS reporting.
Frequently Asked Questions about Regenmed Development Organization
Is Regenmed Development Organization a legitimate charity?
Regenmed Development Organization (EIN: 202710571) is a registered tax-exempt nonprofit based in North Carolina. Our AI analysis gives it a Mission Score of 85/100. It has 14 years of IRS 990 filings on record. Total revenue: $4.1M. 3 red flags identified. 3 strengths noted. Financial health grade: C.
How does Regenmed Development Organization spend its money?
Regenmed Development Organization directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to Regenmed Development Organization tax-deductible?
Regenmed Development Organization is registered as a tax-exempt nonprofit (EIN: 202710571). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of Regenmed Development Organization's spending goes to programs?
Regenmed Development Organization directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Regenmed Development Organization compare to similar nonprofits?
With a transparency score of 85/100 (Excellent), Regenmed Development Organization is above average for NTEE category H12 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Regenmed Development Organization located?
Regenmed Development Organization is headquartered in Winstonsalem, North Carolina and files with the IRS under EIN 202710571. It is classified under NTEE code H12.
How many years of IRS 990 filings does Regenmed Development Organization have?
Regenmed Development Organization has 14 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $4.1M in total revenue.
How does Regenmed Development Organization fund its executive leadership if officer compensation is consistently 0%?
The consistent reporting of 0% officer compensation across all filings suggests that executive leadership may be entirely volunteer-based, compensated through a related entity, or funded by external grants not reported as direct compensation on the 990.
What caused the significant decrease in assets from $3,311,743 in 2019 to $565,309 in 2023?
The filings do not provide specific details for this decline, but potential reasons could include significant asset liquidation to cover operational expenses, investment losses, or a shift in asset management strategy.
What is the detailed breakdown of program, administrative, and fundraising expenses?
The provided data does not offer a granular breakdown of expenses beyond total expenses. A detailed Schedule G or Statement of Functional Expenses from the 990 would be needed to accurately assess these categories.
How does the organization manage to operate with liabilities often exceeding or closely matching assets, as seen in 2023 ($600,696 liabilities vs. $565,309 assets)?
This indicates a tight financial position, potentially relying on short-term funding or grants to cover immediate obligations. It suggests limited financial reserves and a need for careful cash flow management.
Filing History
IRS 990 filing history for Regenmed Development Organization showing financial trends over 14 years of public records:
Over 14 years of IRS 990 filings (2011–2023), Regenmed Development Organization's revenue has grown by 621.8%, moving from $162K to $1.2M. Total assets increased by 2149.4% over the same period, from $25K to $565K. Total functional expenses rose by 531.5%, from $187K to $1.2M. In its most recent filing year (2023), Regenmed Development Organization reported a deficit of $15K, with expenses exceeding revenue. The organization holds $601K in liabilities against $565K in assets (debt-to-asset ratio: 106.3%), resulting in net assets of $-35,387.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $1.2M | $1.2M | $565K | $601K | — | — |
| 2022 | $986K | $1.0M | $3.2M | $3.2M | — | View 990 |
| 2021 | $1.1M | $1.1M | $1.9M | $1.9M | — | View 990 |
| 2021 | $2.0M | $2.1M | $847K | $823K | — | — |
| 2020 | $2.1M | $2.2M | $1.5M | $1.4M | — | View 990 |
| 2019 | $2.1M | $2.1M | $3.3M | $3.2M | — | View 990 |
| 2018 | $1.8M | $1.8M | $1.8M | $1.7M | — | View 990 |
| 2017 | $829K | $631K | $598K | $400K | — | View 990 |
| 2016 | $0 | $0 | $1 | $0 | — | View 990 |
| 2015 | $0 | $98 | $1 | $0 | — | — |
| 2014 | $152K | $156K | $98 | $0 | — | View 990 |
| 2013 | $21K | $21K | $5K | $0 | — | View 990 |
| 2012 | $37K | $37K | $5K | $0 | — | View 990 |
| 2011 | $162K | $187K | $25K | $0 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $1.2M, expenses of $1.2M, and assets of $565K (revenue +18.5% year-over-year).
- 2022: Revenue of $986K, expenses of $1.0M, and assets of $3.2M (revenue -8.9% year-over-year).
- 2021: Revenue of $1.1M, expenses of $1.1M, and assets of $1.9M (revenue -46.5% year-over-year).
- 2021: Revenue of $2.0M, expenses of $2.1M, and assets of $847K (revenue -5.1% year-over-year).
- 2020: Revenue of $2.1M, expenses of $2.2M, and assets of $1.5M (revenue +3.5% year-over-year).
- 2019: Revenue of $2.1M, expenses of $2.1M, and assets of $3.3M (revenue +17.3% year-over-year).
- 2018: Revenue of $1.8M, expenses of $1.8M, and assets of $1.8M (revenue +111.7% year-over-year).
- 2017: Revenue of $829K, expenses of $631K, and assets of $598K.
- 2016: Revenue of $0, expenses of $0, and assets of $1.
- 2015: Revenue of $0, expenses of $98, and assets of $1 (revenue -100.0% year-over-year).
- 2014: Revenue of $152K, expenses of $156K, and assets of $98 (revenue +635.3% year-over-year).
- 2013: Revenue of $21K, expenses of $21K, and assets of $5K (revenue -45.0% year-over-year).
- 2012: Revenue of $37K, expenses of $37K, and assets of $5K (revenue -76.8% year-over-year).
- 2011: Revenue of $162K, expenses of $187K, and assets of $25K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Regenmed Development Organization:
Data Sources and Methodology
This transparency report for Regenmed Development Organization is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.